Italian regulator probes Roche/Novartis cartel claims
This article was originally published in Scrip
Executive Summary
The Italian competition authority has launched an investigation into Roche and Novartis following complaints that they may be operating an illegal cartel to prevent the use of the Avastin (Roche's bevacizumab) in ophthalmic indications.